本页面由Tiger Trade Technology Pte. Ltd.提供服务

Day One Biopharmaceuticals Inc.

21.41
+0.01000.05%
盘后21.420.0100+0.05%17:50 EDT
成交量:236.76万
成交额:5,070.64万
市值:22.12亿
市盈率:-20.59
高:21.44
开:21.43
低:21.40
收:21.40
52周最高:21.46
52周最低:5.64
股本:1.03亿
流通股本:7,876.62万
量比:0.71
换手率:3.01%
股息:- -
股息率:- -
每股收益(TTM):-1.0400
每股收益(LYR):-1.0400
净资产收益率:-22.74%
总资产收益率:-14.64%
市净率:5.01
市盈率(LYR):-20.59

数据加载中...

2021/12/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/29

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/29

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/18

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/08/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/17

重要事件披露

8-K - Current report
2021/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/10

重要事件披露

8-K - Current report
2021/06/10

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/26

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/24

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/24

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/24

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/04

SEC问询函

CORRESP [Cover] - Correspondence